Find clinical trials for Glioblastoma (GBM) in Tampa, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Glioblastoma

Recurrence

Brain Cancer

Glioma

Cancer

Astrocytoma

Gliosarcoma

Glioblastoma (GBM) trials near Tampa, FL, USA:

INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)

efficacy of INO-5401 and INO-9012 in combination with cemiplimab (REGN2810), with radiation and chemotherapy, in subjects with newly-diagnosed glioblastoma...

Active, not recruiting

Glioblastoma

Drug: Temozolomide

Biological: INO-5401

Phase 1, Phase 2

Inovio Pharmaceuticals

Tampa, Florida, United States and 20 other locations

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

The primary purpose of the study is to determine the efficacy of an investigational therapy called DCVax(R)-L in patients with newly diagnosed GBM...

Active, not recruiting

Glioblastoma

Glioblastoma Multiforme

Drug: Dendritic cell immunotherapy

Phase 3

Northwest Biotherapeutics

Tampa, Florida, United States and 85 other locations

GammaTile and Stupp in Newly Diagnosed GBM (GESTALT)

In summary, standard of care postoperative chemoradiation for patients with newly diagnosed GBM does not routinely provide durable local con...

Enrolling

Glioblastoma

Device: Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide)

Phase 4

GT Medical Technologies

Tampa, Florida, United States and 10 other locations

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma (GBM AGILE)

Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM AGILE) is an international, seamless Phase II/II....

Enrolling

Glioblastoma

Drug: Temozolomide

Radiation: Radiation

Phase 2, Phase 3

Global Coalition for Adaptive Research

Tampa, Florida, United States and 61 other locations

Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations (FIGHT-209)

This is an open-label, monotherapy study of pemigatinib in participants with recurrent glioblastoma (GBM) or other recurrent glioma...

Active, not recruiting

Glioblastoma

Adult-type Diffuse Gliomas

Drug: Pemigatinib

Phase 2

Incyte

Tampa, Florida, United States and 80 other locations

A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed Glioblastoma

the return of cancer in patients with a newly diagnosed or recurrent glioblastoma multiforme (GBM) in combination with standard che...

Enrolling

Glioblastoma

Biological: Autologous genetically modified gamma-delta T cells

Biological: Allogeneic genetically modified gamma-delta T cells

Phase 1, Phase 2

In8bio

Tampa, Florida, United States and 7 other locations

Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM (EF-32)

To test the effectiveness and safety of Optune® given concomitantly with radiation therapy (RT) and temozolomide (TMZ) in newly diagnosed GBM...

Active, not recruiting

Glioblastoma Multiforme

Device: Optune®

NovoCure

Tampa, Florida, United States and 132 other locations

A Phase 3, Controlled, Open-label, Global Randomized Study of RRx-001 With a Platinum Doublet or a Platinum Doublet in Small Cell Lung Cancer (REPLATINUM)

This Global Phase 3 study aims to find out whether RRx-001 + platinum chemotherapy is more effective than platinum chemotherapy alone in 3rd line or...

Enrolling

Carcinoma, Small Cell Lung

Drug: RRx-001 + eLOOP Device

Drug: Cisplatin/carboplatin plus etoposide

Phase 3

EpicentRx

Tampa, Florida, United States and 2 other locations

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors (SPARTA)

To assess:* efficacy of APL-101 as monotherapy for the treatment of NSCLC harboring MET Exon 14 skipping mutations, NSCLC harboring MET amplification...

Enrolling

Glioblastoma Multiforme

Brain Tumor

Drug: APL-101 Oral Capsules

Phase 2

Apollomics

Tampa, Florida, United States and 90 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Glioblastoma (GBM) in .css-epvm6{white-space:nowrap;}Tampa, FL

Related conditions:

Glioblastoma (GBM) trials near Tampa, FL, USA:

INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

GammaTile and Stupp in Newly Diagnosed GBM (GESTALT)

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma (GBM AGILE)

Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations (FIGHT-209)

A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed Glioblastoma

Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM (EF-32)

A Phase 3, Controlled, Open-label, Global Randomized Study of RRx-001 With a Platinum Doublet or a Platinum Doublet in Small Cell Lung Cancer (REPLATINUM)

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors (SPARTA)

Find clinical trials for Glioblastoma (GBM) in Tampa, FL